Dabigatran EMA - product-specific guide [Regulatives / Guidelines]

posted by nobody – 2019-02-14 16:01 (1922 d 13:51 ago) – Posting: # 19921
Views: 4,467

❝ ❝ ❝ Aren’t you notoriously shouting “It’s the originator, stupid…”?

❝ ❝ Could you elaborate on this. No clue what this might mean.

❝ See there.

yeah, but you need irony tags in here,don'T you?

❝ ❝ If you want a duel, choose your weapon

❝ ❝ :hungry:

❝ Surströmming?

No chemical weapons.

❝ ❝ ❝ I’m more concerned about the first footnote in the guidance […]. Was the EMA’s PKWP not aware of the the FDA’s guidance?

❝ ❝

❝ ❝ Narrow therapeutic range... maybe in the USA. In the EU there are no mass tort trials...

❝ I don’t like the idea that someone widens the limits for this stuff.

...maybe we will never see such generics in our lifetime. Wait and see...

Kindest regards, nobody

Complete thread:

UA Flag
 Admin contact
23,033 posts in 4,835 threads, 1,647 registered users;
39 visitors (0 registered, 39 guests [including 4 identified bots]).
Forum time: 06:53 CEST (Europe/Vienna)

Give me a fruitful error any time, full of seeds, bursting with its own corrections.
You can keep your sterile truth for yourself.    Vilfredo Pareto

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz